Cargando…
Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
Background: Blockade of tumour necrosis factor (anti-TNF) is effective in patients with Crohn’s Disease but has been associated with infection risk and neurological complications such as demyelination. Niemann-Pick disease Type C1 (NPC1) is a lysosomal storage disorder presenting in childhood with...
Autores principales: | Williams, Isabelle, Pandey, Sumeet, Haller, Wolfram, Huynh, Hien Quoc, Chan, Alicia, Düeker, Gesche, Bettels, Ruth, Peyrin-Biroulet, Laurent, Dike, Chinenye R., DeGeeter, Catherine, Smith, David, Al Eisa, Nada, Platt, Nick, Marquardt, Thorsten, Schwerd, Tobias, Platt, Frances M., Uhlig, Holm H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171292/ https://www.ncbi.nlm.nih.gov/pubmed/35694196 http://dx.doi.org/10.12688/wellcomeopenres.16986.1 |
Ejemplares similares
-
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease
por: Schwerd, Tobias, et al.
Publicado: (2017) -
Immune dysfunction in Niemann‐Pick disease type C
por: Platt, Nick, et al.
Publicado: (2015) -
The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann–Pick disease type C
por: Platt, Frances M.
Publicado: (2023) -
A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease
por: Giese, Anne-Katrin, et al.
Publicado: (2015) -
Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteria
por: Weng, Yuzhe, et al.
Publicado: (2022)